These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23141631)

  • 1. Neurocognitive functioning in the prodrome of mania--an exploratory study.
    Ratheesh A; Lin A; Nelson B; Wood SJ; Brewer W; Betts J; Berk M; McGorry P; Yung AR; Bechdolf A
    J Affect Disord; 2013 May; 147(1-3):441-5. PubMed ID: 23141631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
    Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
    Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC; Hua MS; Hwang TJ; Chiu CY; Liu CM; Hsieh MH; Chien YL; Lin YT; Hwu HG
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis.
    Ratheesh A; Cotton SM; Davey CG; Lin A; Wood S; Yuen HP; Bechdolf A; McGorry PD; Yung A; Berk M; Nelson B
    Schizophr Res; 2018 Feb; 192():345-350. PubMed ID: 28768599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognition and social cognition in youth and young adults at ultra-high-risk for psychosis and bipolar disorder.
    Bora E; Eyuboglu MS; Cesim E; Demir M; Yalincetin B; Ermis C; Özbek Uzman S; Sut E; Demirlek C; Verim B; Baykara B; Akay A; İnal N; Akdede BB
    Schizophr Res; 2024 Apr; 266():58-65. PubMed ID: 38368706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General intellectual functioning as a buffer against theory-of-mind deficits in individuals at ultra-high risk for psychosis.
    Hur JW; Byun MS; Shin NY; Shin YS; Kim SN; Jang JH; Kwon JS
    Schizophr Res; 2013 Sep; 149(1-3):83-7. PubMed ID: 23810120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognition in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E; Aparicio AI; Sánchez-Morla EM; Rodriguez-Jimenez R; Vieta E; Santos JL
    J Affect Disord; 2017 Nov; 222():169-176. PubMed ID: 28709024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and neurocognitive profiles of subjects at high risk for psychosis with and without obsessive-compulsive symptoms.
    Hur JW; Shin NY; Jang JH; Shim G; Park HY; Hwang JY; Kim SN; Yoo JH; Hong KS; Kwon JS
    Aust N Z J Psychiatry; 2012 Feb; 46(2):161-9. PubMed ID: 22311532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in neurocognitive functioning during transition to manifest disease: comparison of individuals at risk for schizophrenic and bipolar affective psychoses.
    Metzler S; Dvorsky D; Wyss C; Müller M; Gerstenberg M; Traber-Walker N; Walitza S; Theodoridou A; Rössler W; Heekeren K
    Psychol Med; 2015 Jul; 45(10):2123-34. PubMed ID: 25640248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive functioning in patients recently diagnosed with bipolar disorder.
    Hellvin T; Sundet K; Simonsen C; Aminoff SR; Lagerberg TV; Andreassen OA; Melle I
    Bipolar Disord; 2012 May; 14(3):227-38. PubMed ID: 22548896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predicting bipolar disorder: what can we learn from prospective cohort studies?].
    Geoffroy PA; Leboyer M; Scott J
    Encephale; 2015 Feb; 41(1):10-6. PubMed ID: 24094986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
    Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
    JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of obesity on cognitive functions in individuals at ultra high risk for bipolar disorder: Results from the global mood and brain science initiative.
    McIntyre RS; Mansur RB; Lee Y; Japiassú L; Chen K; Lu R; Lu W; Chen X; Li T; Xu G; Lin K
    Bipolar Disord; 2017 Mar; 19(2):128-134. PubMed ID: 28493605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.
    Lin A; Wood SJ; Nelson B; Brewer WJ; Spiliotacopoulos D; Bruxner A; Broussard C; Pantelis C; Yung AR
    Schizophr Res; 2011 Oct; 132(1):1-7. PubMed ID: 21763109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognition and functional outcome in patients with psychotic, non-psychotic bipolar I disorder, and schizophrenia. A five-year follow-up.
    Jiménez-López E; Sánchez-Morla EM; López-Villarreal A; Aparicio AI; Martínez-Vizcaíno V; Vieta E; Rodriguez-Jimenez R; Santos JL
    Eur Psychiatry; 2019 Feb; 56():60-68. PubMed ID: 30500572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.